CD69 and COVID-19: Overall, our findings demonstrated that, regardless of the time points along the timeline kinetics, CD4+CD38+ and CD8+CD69+ presented outstanding accuracy (AUC ≥ 0.9) in classifying COVID-19 patients vs. HCs.